The effects of 10-mL versus 40-mL capsular dilatation under ultrasound-guided in patients with adhesive capsulitis: A Randomized Controlled Trial

Status

Unknown

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240515005

Enrollment

Registered

2024-05-15

Start date

2023-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient with adhesive capsulitis adhesive capsulitis, intra articular injection, hydrodilatation

Interventions

hydrodilatation small amount at 10 cc injection,hydrodilatation large amount at 40 cc injection

Active Comparator Drug,Active Comparator Drug

hydrodilatation small volume,hydrodilatation large volume

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: VAS score of shoulder >= 4 and limit AROM or PROM at least 2 direction symptom more than a month

Exclusion criteria

Exclusion criteria: Full thickness tear of rotator cuff has previous intra-articular injection within 3 month

Design outcomes

Primary

Measure	Time frame
Visual analog scale (VAS) at 1st visit and post treatment 1 month pain measurement (objective)	—

Secondary

Measure	Time frame
Shoulder Pain and Disability Index at 1st visit and posttreatment 1 month functional assessment	—

Countries

Thailand

Contacts

Public Contactrawipa khunnarong

Phramongkutklao hospital

preawpelin@gmail.com0827797555

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026